Delivery Order SPE2DB24D2100-SPE2DB25FBDBR
Award Date
3/27/25
Potential Completion Date
3/28/25
Potential Value
$1.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,214.78, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the procurement of NEUPOGEN 300 MCG/ML VIALML, a medical product, with a firm fixed price and an ultimate completion date of March 28, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $3,644.34, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order for the supply of the medication NEUPOGEN 300 MCG/ML VIALML, with an ultimate completion date of April 17, 2025. The contract is a firm fixed-price, non-set-aside arrangement. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award is for the delivery of NEUPOGEN 300 MCG/ML vials, a medical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $2,429.58 and is a Firm Fixed Price Delivery Order contract with a period of performance through January 29, 2025. The contract is not designated with a set-aside. Amerisourcebergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,214.78 firm fixed-price delivery order is for the supply of NEUPOGEN 300 MCG/ML VIALML, a specialty pharmaceutical product, with a contract period ending on February 6, 2025. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of NEUPOGEN 480 MCG/0.8 ML SYR 0.8ML. The contract has a total ceiling value of $5,293.88 and an ultimate completion date of May 10, 2024. It is a Firm Fixed Price Delivery Order contract, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of...
This federal contract award, with ID SPE2DB22D2206|SPE2DB25FFY23, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, which is a Delivery Order valued at $6,931.66, is for the supply of NEUPOGEN 480 MCG/0.8 ML SYR 0.8ML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of March 5, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of NEUPOGEN 480 MCG/0.8 ML SYR 0.8ML, a specialty pharmaceutical product. The contract has a firm fixed price of $17,160.11 and a period of performance through November 14, 2024. Amerisourcebergen is a major pharmaceutical distribution and healthcare solutions provider, and this contract is part of the company's broader Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract has an award value of $1,097.52 and is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
This federal contract award, valued at $1,099.26, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of EPOGEN 3,000 units/mL vials, a specialty medication used for the treatment of anemia. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of May 9, 2023. It is not designated as a set-aside contract....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,481.11 firm fixed price delivery order is for the supply of GONAL-F RFF REDI-JECT 900 UNIT 1.5ML, a specialty pharmaceutical product. The award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a...